Old Web
English
Sign In
Acemap
>
authorDetail
>
B. Salvadori
B. Salvadori
Bristol-Myers Squibb
Medicine
Oncology
Epirubicin
Internal medicine
Paclitaxel
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Epirubicin (E) plus paclitaxel (P) vs epirubicin followed by paclitaxel in metastatic breast cancer (MBC): an ongoing pharmacoeconomic study
1998
European Journal of Cancer
A. Redaelli
Editta Baldini
B. Salvadori
D. Aldrighetti
Pierfranco Conte
M. Quattrocchio
M. Svanosio
T. Bergamino
Carmelo Tibaldi
R. Lionetto
Show All
Source
Cite
Save
Citations (0)
P47 Locally advanced breast cancer (LABC): Prognostic variables affecting results
1998
European Journal of Cancer
Editta Baldini
G. Gardin
R. Lionetto
E. Montanaro
B. Salvadori
R. Massa
R. Rosso
Pierfranco Conte
Show All
Source
Cite
Save
Citations (0)
PP-7-3 Epirubicin (E) plus paclitaxel (P) in advanced breast cancer: A regimen with high activity and low cardiac toxicity which mobilizes peripheral blood stem cells
1996
European Journal of Cancer
P.F. Conte
A. Michelotti
E. Baldini
B. Salvadori
A. Gennari
C. Tibaldi
I. Pazzagli
C. Bengala
A. Gentile
Show All
Source
Cite
Save
Citations (0)
934 Paclitaxel (P) and epirubicin (E) in advanced breast (ABC) and ovarian cancer (AOC): A phase I study
1995
European Journal of Cancer
Pierfranco Conte
Andrea Michelotti
A. Romanini
Editta Baldini
P. G. Giannessi
M. DaPrato
Carmelo Tibaldi
M. Conti
A. Tognoni
B. Salvadori
A. Gentile
O. Biadi
Mario Mariani
Show All
Source
Cite
Save
Citations (0)
1